We assign a fundamental rating of 1 out of 10 to QTTB. QTTB was compared to 525 industry peers in the Biotechnology industry. Both the profitability and financial health of QTTB have multiple concerns. QTTB is valued expensive and it does not seem to be growing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -75.58% | ||
| ROE | N/A | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.81 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.71 | ||
| Quick Ratio | 4.71 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 1 / 10 to QTTB.
ChartMill assigns a valuation rating of 1 / 10 to Q32 BIO INC (QTTB). This can be considered as Overvalued.
Q32 BIO INC (QTTB) has a profitability rating of 0 / 10.
The financial health rating of Q32 BIO INC (QTTB) is 3 / 10.